Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Azilsartan Medoxomil + Chlorthalidone vs Olmesartan + HCTZ in Hypertension
NCT00996281Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started Oct 2009; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00996281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996281.